SARS-CoV-2 investigation in cerebrospinal fluid from meningitis patients during the first pandemic wave

SARS-CoV-2 predominantly affects the respiratory system; however, during the first pandemic wave, there was a concern about its neuroinvasive potential due to its ability to replicate in neural cells and the neurological signs widely reported as impaired taste or smell. This study aimed to evaluate...

Full description

Saved in:
Bibliographic Details
Main Authors: Maria Cecilia Cergole-Novella, Thayná Rosa Bispo, Elaine Monteiro Matsuda, Daniela Rodrigues Colpas, Ivana Barros de Campos
Format: Article
Language:English
Published: Elsevier 2025-09-01
Series:Brazilian Journal of Infectious Diseases
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S1413867025000728
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849340471453679616
author Maria Cecilia Cergole-Novella
Thayná Rosa Bispo
Elaine Monteiro Matsuda
Daniela Rodrigues Colpas
Ivana Barros de Campos
author_facet Maria Cecilia Cergole-Novella
Thayná Rosa Bispo
Elaine Monteiro Matsuda
Daniela Rodrigues Colpas
Ivana Barros de Campos
author_sort Maria Cecilia Cergole-Novella
collection DOAJ
description SARS-CoV-2 predominantly affects the respiratory system; however, during the first pandemic wave, there was a concern about its neuroinvasive potential due to its ability to replicate in neural cells and the neurological signs widely reported as impaired taste or smell. This study aimed to evaluate the presence of SARS-CoV-2 in cerebrospinal fluid (CSF) from suspected cases of meningitis. During the first year of the pandemic, from January 2020 to February 2021, CSF samples were first submitted to multiplex qPCR to detect the three main bacteria causing meningitis (Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae), as the routine of the laboratory, but also, they were submitted to RT-qPCR to SARS-CoV-2 detection. Some samples (20 %) were positive for one bacterium; however, none were positive for the virus, suggesting that the incidence of SARS-CoV-2 in meninges is extremely low. This study with other data in the literature contributes to the epidemiologic surveillance of SARS-CoV-2.
format Article
id doaj-art-3d98a8bb0fbb4a08be099a212e7740e1
institution Kabale University
issn 1413-8670
language English
publishDate 2025-09-01
publisher Elsevier
record_format Article
series Brazilian Journal of Infectious Diseases
spelling doaj-art-3d98a8bb0fbb4a08be099a212e7740e12025-08-20T03:43:55ZengElsevierBrazilian Journal of Infectious Diseases1413-86702025-09-0129510457110.1016/j.bjid.2025.104571SARS-CoV-2 investigation in cerebrospinal fluid from meningitis patients during the first pandemic waveMaria Cecilia Cergole-Novella0Thayná Rosa Bispo1Elaine Monteiro Matsuda2Daniela Rodrigues Colpas3Ivana Barros de Campos4Instituto Adolfo Lutz, Centro de Laboratório Regional Santo André, Santo André, SP, BrazilInstituto Adolfo Lutz, Centro de Laboratório Regional Santo André, Santo André, SP, BrazilPrefeitura Municipal de Santo André, Secretaria de Saúde de Santo André, Santo André, SP, BrazilInstituto Adolfo Lutz, Centro de Laboratório Regional Santo André, Santo André, SP, BrazilInstituto Adolfo Lutz, Centro de Laboratório Regional Santo André, Santo André, SP, Brazil; Corresponding author.SARS-CoV-2 predominantly affects the respiratory system; however, during the first pandemic wave, there was a concern about its neuroinvasive potential due to its ability to replicate in neural cells and the neurological signs widely reported as impaired taste or smell. This study aimed to evaluate the presence of SARS-CoV-2 in cerebrospinal fluid (CSF) from suspected cases of meningitis. During the first year of the pandemic, from January 2020 to February 2021, CSF samples were first submitted to multiplex qPCR to detect the three main bacteria causing meningitis (Neisseria meningitidis, Streptococcus pneumoniae, and Haemophilus influenzae), as the routine of the laboratory, but also, they were submitted to RT-qPCR to SARS-CoV-2 detection. Some samples (20 %) were positive for one bacterium; however, none were positive for the virus, suggesting that the incidence of SARS-CoV-2 in meninges is extremely low. This study with other data in the literature contributes to the epidemiologic surveillance of SARS-CoV-2.http://www.sciencedirect.com/science/article/pii/S1413867025000728SARS-CoV-2RT-qPCRMeningitisCerebrospinal fluid
spellingShingle Maria Cecilia Cergole-Novella
Thayná Rosa Bispo
Elaine Monteiro Matsuda
Daniela Rodrigues Colpas
Ivana Barros de Campos
SARS-CoV-2 investigation in cerebrospinal fluid from meningitis patients during the first pandemic wave
Brazilian Journal of Infectious Diseases
SARS-CoV-2
RT-qPCR
Meningitis
Cerebrospinal fluid
title SARS-CoV-2 investigation in cerebrospinal fluid from meningitis patients during the first pandemic wave
title_full SARS-CoV-2 investigation in cerebrospinal fluid from meningitis patients during the first pandemic wave
title_fullStr SARS-CoV-2 investigation in cerebrospinal fluid from meningitis patients during the first pandemic wave
title_full_unstemmed SARS-CoV-2 investigation in cerebrospinal fluid from meningitis patients during the first pandemic wave
title_short SARS-CoV-2 investigation in cerebrospinal fluid from meningitis patients during the first pandemic wave
title_sort sars cov 2 investigation in cerebrospinal fluid from meningitis patients during the first pandemic wave
topic SARS-CoV-2
RT-qPCR
Meningitis
Cerebrospinal fluid
url http://www.sciencedirect.com/science/article/pii/S1413867025000728
work_keys_str_mv AT mariaceciliacergolenovella sarscov2investigationincerebrospinalfluidfrommeningitispatientsduringthefirstpandemicwave
AT thaynarosabispo sarscov2investigationincerebrospinalfluidfrommeningitispatientsduringthefirstpandemicwave
AT elainemonteiromatsuda sarscov2investigationincerebrospinalfluidfrommeningitispatientsduringthefirstpandemicwave
AT danielarodriguescolpas sarscov2investigationincerebrospinalfluidfrommeningitispatientsduringthefirstpandemicwave
AT ivanabarrosdecampos sarscov2investigationincerebrospinalfluidfrommeningitispatientsduringthefirstpandemicwave